-
1
-
-
0026681119
-
Prevalence of age-related maculopathy: The Beaver Dam Eye Study
-
Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992;99:933- 43.
-
(1992)
Ophthalmology
, vol.99
, pp. 933-943
-
-
Klein, R.1
Klein, B.E.2
Linton, K.L.3
-
2
-
-
0028839002
-
The prevalence of age-related maculopathy in the Rotterdam study
-
Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995;102:205-10.
-
(1995)
Ophthalmology
, vol.102
, pp. 205-210
-
-
Vingerling, J.R.1
Dielemans, I.2
Hofman, A.3
-
4
-
-
0342632445
-
Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: One-year results of 2 randomised clinical trials. TAP
-
TAP study group
-
TAP study group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomised clinical trials. TAP report 1. Arch Ophthalmol 1999;117:1239-45.
-
(1999)
Arch Ophthalmol
, vol.117
, pp. 1239-1245
-
-
-
5
-
-
0035124965
-
Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: Two-year results of 2 randomised clinical trials. TAP
-
TAP study group
-
TAP study group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: two-year results of 2 randomised clinical trials. TAP report 2. Arch Ophthalmol 2001;119:198-207.
-
(2001)
Arch Ophthalmol
, vol.119
, pp. 198-207
-
-
-
6
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
-
(2006)
N Engl J Med
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
-
7
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44.
-
(2006)
N Engl J Med
, vol.355
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
-
8
-
-
11144239923
-
Pegaptanib for neovascular age-related macular degeneration
-
Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
-
(2004)
N Engl J Med
, vol.351
, pp. 2805-2816
-
-
Gragoudas, E.S.1
Adamis, A.P.2
Cunningham Jr, E.T.3
-
10
-
-
0025736267
-
Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS
-
Early Treatment Diabetic Retinopathy Study Research Group
-
Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS Report Number 7. Ophthalmology 1991;98:741-56.
-
(1991)
Ophthalmology
, vol.98
, pp. 741-756
-
-
-
11
-
-
0020027985
-
Macular Photocoagulation Study. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial
-
Macular Photocoagulation Study. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthamol 1982;100:912-18.
-
(1982)
Arch Ophthamol
, vol.100
, pp. 912-918
-
-
-
12
-
-
0034018598
-
Macular degeneration: Do conventional measurements of impaired vision equate with visual disability?
-
McClure ME, Hart PM, Jackson AJ, et al. Macular degeneration: do conventional measurements of impaired vision equate with visual disability? Br J Ophthalmol 2000;84:244-50.
-
(2000)
Br J Ophthalmol
, vol.84
, pp. 244-250
-
-
McClure, M.E.1
Hart, P.M.2
Jackson, A.J.3
-
13
-
-
0036822175
-
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials-TAP Report no. 5
-
TAP Study Group
-
TAP Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials-TAP Report no. 5. Arch Ophthalmol 2002;120:1307-14.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1307-1314
-
-
-
14
-
-
4344583798
-
Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: The UK case
-
Smith DH, Fenn P, Drummond M. Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case. Br J Ophthalmol 2004;88:1107-12.
-
(2004)
Br J Ophthalmol
, vol.88
, pp. 1107-1112
-
-
Smith, D.H.1
Fenn, P.2
Drummond, M.3
|